IPF Summit 2019

ERT is proud to be speaking at the IPF Summit. Phil Lake, Senior Director of Respiratory Solutions, will be presenting “The Use of Active Indication Management to Drive Higher Quality Outcomes Data.” The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics.

For more details on efficacy and safety solutions that capture ~100% acceptable data in real-time that exceed ATS and ERS standards visit https://www.ert.com/respiratory/ or schedule an onsite meeting with Aisha Luvert.